Case Report of Mesorectal Failure in the Treatment of Prostate Adenocarcinoma

Article Sidebar

PDF Download
Published Nov 28, 2022
DOI: https://doi.org/10.18103/mra.v10i11.3266

Downloads

Download data is not yet available.

Submit your own article

Register as an author to reserve your spot in the next issue of the Medical Research Archives.

Author Registration

Join the Society

The European Society of Medicine is more than a professional association. We are a community. Our members work in countries across the globe, yet are united by a common goal: to promote health and health equity, around the world.

Join Europe’s leading medical society and discover the many advantages of membership, including free article publication.

Membership

Main Article Content

James L Shen, PhD
Medical Scientist Training Program, UMass Chan Medical School, Worcester, MA 01655, USA
John G Roubil, MD
Department of Radiation Oncology, UMass Chan Medical School, Worcester, MA 01655, USA
Linda Ding, PhD
Department of Radiation Oncology, UMass Chan Medical School, Worcester, MA 01655, USA
Julie Trifone, CMD
Department of Radiation Oncology, UMass Chan Medical School, Worcester, MA 01655, USA
Carla Bradford, PhD
Department of Radiation Oncology, UMass Chan Medical School, Worcester, MA 01655, USA
Fenghong Liu, PhD
Department of Radiation Oncology, UMass Chan Medical School, Worcester, MA 01655, USA
Yankhua Fan, PhD
Department of Radiation Oncology, UMass Chan Medical School, Worcester, MA 01655, USA
I-Lin Kuo, PhD
Department of Radiation Oncology, UMass Chan Medical School, Worcester, MA 01655, USA
Camelia Bunaciu, MS
Department of Radiation Oncology, UMass Chan Medical School, Worcester, MA 01655, USA
Salvatore Larosa, MS
Department of Radiation Oncology, UMass Chan Medical School, Worcester, MA 01655, USA
Suhong Yu, PhD
Department of Radiation Oncology, UMass Chan Medical School, Worcester, MA 01655, USA
Abdulnasser Khalifeh, PhD
Department of Radiation Oncology, UMass Chan Medical School, Worcester, MA 01655, USA
Jonathan Saleeby, MS
Department of Radiation Oncology, UMass Chan Medical School, Worcester, MA 01655, USA
Harry Bushe, MS
Department of Radiation Oncology, UMass Chan Medical School, Worcester, MA 01655, USA
Maryann Bishop-Jodoin, MEd
Department of Radiation Oncology, UMass Chan Medical School, Worcester, MA 01655, USA
Thomas J. FitzGerald, MD
Department of Radiation Oncology, UMass Chan Medical School, Worcester, MA 01655, USA

Abstract

Prostate cancer afflicts a substantial portion of the male population with increasing incidence each decade after the age of 40. Standard of care for localized disease at presentation includes prostatectomy and/or radiation therapy which can include management of pelvic lymph nodes. However, the selection of lymph nodes treated by radiotherapy remains variable among practitioners including individual practitioners in the same institution. We present a patient with prostate adenocarcinoma who underwent radical prostatectomy with adjuvant radiotherapy for lymph node involvement and developed mesorectal failure secondary to metastatic spread to untreated tissue.

Keywords: Prostate cancer, Radiation therapy, Mesorectal

Article Details

How to Cite
SHEN, James L et al. Case Report of Mesorectal Failure in the Treatment of Prostate Adenocarcinoma. Medical Research Archives, [S.l.], v. 10, n. 11, nov. 2022. ISSN 2375-1924. Available at: <https://esmed.org/MRA/mra/article/view/3266>. Date accessed: 21 nov. 2024. doi: https://doi.org/10.18103/mra.v10i11.3266.
ABNT APA BibTeX CBE EndNote - EndNote format (Macintosh & Windows) MLA ProCite - RIS format (Macintosh & Windows) RefWorks Reference Manager - RIS format (Windows only) Turabian
Issue
Vol 10 No 11 (2023): NOVEMBER ISSUE, VOl. 10 ISsue 11
Section
Case Reports

The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.

 

References

1. Howlader N, Noone AM, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2016. National Cancer Institute. https://seer.cancer.gov/csr/1975_2016/, 2019.
2. Bekelman JE, Rumble RB, Chen RC, et al. Clinically localized prostate cancer: ASCO Clinical Practice Guideline endorsement of an American Urological Association/American Society for Radiation Oncology/Society of Urologic Oncology Guideline. J Clin Oncol. 2018;36(32):3251-3258.
3. Sanda MG, Cadeddu JA, Kirkby E, et al. Clinically localized prostate cancer: AUA/ASTRO/SUO Guideline. Part I: Risk stratification, shared decision making, and care options. J Urol. 2018;199(3):683-690.
4. Sanda MG, Cadeddu JA, Kirkby E, et al. Clinically localized prostate cancer: AUA/ASTRO/SUO Guideline. Part II: Recommended approaches and details of specific care options. J Urol. 2018;199(4):990-997.
5. Li G, Li Y, Wang J, et al. Guidelines for radiotherapy of prostate cancer (2020 edition). Precision Radiation Oncology. 2021;5(3):160-182.
6. Rogowski P, Roach M, Schmidt-Hegemann NS, et al. Radiotherapy of oligometastatic prostate cancer: a systematic review. Radiat Oncol. 2021:16:50.
7. Nicosia L, Franzese C, Mazzola R, et al. Recurrence pattern of stereotactic body radiotherapy in oligometastatic prostate cancer: a multi-institutional analysis. Strahlenther Onkol. 2020;196(3):213-221.
8. Soldatov A, von Klot CAJ, Walacides D, et al. Patterns of progression after 68Ga-PSMA-Ligand PET/CT-guided radiation therapy for recurrent prostate cancer. Int J Radiat Oncol Biol Phys. 2019;103(1):95-104.
9. Tran S, Jorcano S, Falco T, Lamanna G, Miralbell R, Zilli T. Oligorecurrent nodal prostate cancer: Long-term results of an elective nodal irradiation approach. Am J Clin Oncol. 2018;41(10):960-962.

Most read articles by the same author(s)